Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposureResearch in context

• Main Authors: Gagandeep Kang (Author), Anand Lakhkar (Author), Chetanraj Bhamare (Author), Abhijeet Dharmadhikari (Author), Jyoti Narwadkar (Author), Arti Kanujia (Author), Dhananjay Kapse (Author), Bhagwat Gunale (Author), Cyrus S. Poonawalla (Author), Prasad S. Kulkarni (Author)
• Format: Book
• Published: Elsevier, 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: A vero cell-based inactivated Rabies Vaccine (Rabivax-S) and Rabies Human Monoclonal Antibody (Rabishield) have been approved since 2016. A post-marketing surveillance was conducted in India from 2020 to 2021 to gather real world safety data on Rabivax-S and Rabishield. Methods:...